Abstract Four new phenolic amides, 4-O-methylgrossamide (1), (4), together with thirteen known phenolic amides were identified from the stem of Lycium barbarum. The structures of the new compounds were determined by spectroscopic methods. All compounds were evaluated for their anti-cancer activities against human glioma stem cell lines.
Introduction
Lycium barbarum had a long history of usage as a traditional herbal medicine and functional food in Asian countries [1] . Besides, its fruits known as goji or wolf berries, were beneficial to human health and very important agricultural products [2, 3] . Modern pharmacological studies indicated L. barbarum possessed widely health-promoting and medical effects, including antioxidant [4] , lipotropic [5] , hepatic function protecting effects [5] , immunomodulatory properties [6] , antiaging [7] , anticancer activities [8] [9] [10] [11] and so on. Phytochemical studies showed that phenolic amides were not only characteristic compounds but also abundant ones in L. Barbarum [2] . Phenolic amides, originating from the condensation of cinnamic acid derivatives and tyramines, octopamines or aliphatic amines [2, 12] , had been reported a range of biological activities, like antioxidant [4] , antiobesity [13] , cytotoxicity [14] , anti-inflammatory activity [15] and potent inhibitors of de novo nucleotide biosynthesis [16] , and they also seemed to play an important role in plant defense against pathogens [12] . Continuation of our study on the phenolic amides had led to the isolation of four new phenolic amides, 4 
-O-methylgrossamide (1), (E)-2-(4,5-dihydroxy-2-{3-[(4-hydroxyphenethyl)amino]-3-oxopropyl}-phenyl)-3-(4-hydroxy-3-methoxyphenyl)-N-(4-hydroxyphenethyl)acryl-amide (2), (Z)-lyciumamide C (3), (Z)-thoreliamide B (4)
, together with thirteen known phenolic amides ( Fig. 1 ) from L. barbarum. The known compounds were identified as grossamide (5) [17] , lyciumamide C (6) [4] , (Z)-3-{(2,3-trans)-2-(4-hydroxy-3-methoxy-phenyl)-3-hydroxymethyl-2,3-dihydrobenzo [1, 4 ]-dioxin-6-yl}-N-(4-hydroxyphenethyl)acrylamide (7), [18] (E)-3-{(2,3-trans)-2-(4-hydroxy-3-methoxyphenyl)-3-hydroxy-methyl-2,3-dihydrobenzo [1, 4] dioxin-6-yl}-N-(4-hydroxyphene thyl)acryl-amide (8) [18] , (E)-thoreliaide B (9) [19] , cannabisin E (10) [20] , cannabisin D (11) [21] , 1,2-dihydro-6,8-dimethoxy-7-hydroxyl-(3,5-dimethoxy-4-hydroxyphenyl)-N 0 ,N-2-bis[2-(4-hydroxyphenyl)ethyl]-2,3-naphthal-enedicarboxamide (12) [22] , cannabisin G (13) [20] , N-E-p-coumaroyl tyramine (14) [23] , N-E-caffeoyl tyramine (15) [24] , N-E-feruloyl tyramine (16) [25] , N-E-feruloyl octopamine (17) [25] , by comparison with the data in the literature values. All of the compounds were evaluated for anti-cancer activity against human glioma stem cell lines, and compounds 1 and 5 exhibited moderate anti-cancer activities. Herein the isolation, structural elucidation and the bioactivity of the phenolic compounds were reported.
Results and Discussion
Compound 1 was obtained as a white powder. Its molecular formula was determined to be C 37 0 ). According to these 1D NMR data (Table 1) , compound 1 was readily identified as a phenolic amide with two tyramine moieties [18] . Detailed analysis of 1D NMR spectra of 1 displayed similarities to those of 5 [27] , except for a methoxy at C-4 in 1 instead of a hydrogen at C-4 in 5, which indicated by HMBC correlations from d . The configuration of H-7 with H-8 was threo, which was assigned by the ROESY correlations of H-8 and H-6 (Fig. 3) , while there was no REOSY correlation between H-7 and H-8 [28] . The absolute configuration at C-7 and C-8 were 7R, 8S, respectively, which determined by the negative cotton effect at 257 nm (De -0.45) observed in circular dichroic spectrum [28] [29] [30] [31] . Detailed analysis of 2D NMR data (HSQC, HMBC, ROESY) established the structure of 1 to be as shown, named 4-O-methylgrossamide.
Compound 2 was obtained as a yellow powder. Its molecular formula C 35 The Anticancer Activities Phenolic Amides 423 (Fig. 2) . ROESY correlation of H-6 with H-5 0 (Fig. 3) suggested two benzene rings, connected to C-7 and C-8 respectively, were on the same side, further confirmed the double bond of C-7/C-8 was E [18] . Hence, Detailed analysis of 2D NMR data established the structure of compound 2 to be as shown,
The other phenolic amide, 3, obtained as a white powder, with the same R f value on silica plate as that of 6, showed identical physical data in the HRESIMS and IR spectra, indicating the existence of the same molecular formula and functional groups as in 6 [4] . The 1D-NMR displayed an AA 0 BB 0 system [26] (Fig. 2 ). Detailed analysis of 1D, 2D NMR spectral data (Table 2) suggested that the planar structure of 3 was the same as 6. The visible difference was that the configuration of the double bond at C-7/C-8 in 3 was Z, which was suggested by coupling constants (J = 12.6 Hz) between H-7 and H-8 [4, 25] . The NOESY correlations of H-7
0 and H-8 0 suggested the configuration of H-7 0 /H-8 0 was erythro (Fig. 3) [4] , which also supported by the specific optical rotation of 3 ½½a . Other parts of the structure were identical to those of 6 by detailed analysis of its 2D NMR spectra. Thus, the structure of 3 was established and named Z-lyciumamide C.
The aromatic rings of the phenylpropanoid units exhibited various oxygenation patterns, and it had been summarized that the deoxygenation patterns might involve the 3,4-, 2,4-, 2,5-and 2,6-positions [4, 17, [19] [20] [21] , but seldom the 3,5-positions [18] . Some compounds which had 3,5-positions substituents The Anticancer Activities Phenolic Amides 425 always been proven to be 3,4-2,4-or 2,5-positions substituents, owing to the existence of ''deceptively simple'' protons signals when changed the deuterated solvent or temperature [32] . Interestingly, in our experiment, the ''deceptively simple'' protons signals that exhibited two broad singlets with approximate integrations of 1:2 for H-2 0 and for H-5
0 , H-6 0 were found when using DMSO-d 6 , and they would be a set of proton signals with a m-coupling constant for H-2 (Fig. 3) . Other parts of the structure were identical to those of 9 by detailed analysis of its 2D NMR spectra. Thus, compound 4 was assigned as (Z)-thoreliamide B.
A literature survey shows that the E-isomers of this type of compounds are widespread in some genera and small amount of Z-isomers [12, 18] . In this paper, three pairs of Z-E-isomers (3 and 6; 4 and 9; 7 and 8) were reported. Due to their different retention times on the Rp-C 18 column, every pair of isomers was separated by HPLC.
All the compounds were evaluated for their bioactivity against two human glioma stem cell lines (GSC-3# and GSC-12#), by the cell viability assay and phenotypic screening. The results showed that compound 5 exhibited the moderate cytotoxicity against GSC-3# and GSC-12# at the concentration of 10 lg/mL (Fig. 4a) , and the IC 50 values were 6.40 and 5.85 lg/mL respectively (Fig. 5) . Compound 1 showed the moderate cytotoxicity against GSC-3# and GSC-12# at the concentration of 25 lg/mL (Fig. 4b) , and the IC 50 values were 28.51 and 19.67 lg/mL respectively (Fig. 5 ).
Experimental Section

General Experimental Procedures
Optical rotations were measured on a JASCO P-1020 polarimeter. UV spectra were detected on a SHMADZU Table 2 1 H (500 MHz) and 13 C NMR (125 MHz) Data for compounds 3 and 6 in DMSO-d 6 and CD 3 The Anticancer Activities Phenolic Amides 427 UV-2401PC spectrometer. IR spectra were determined on a Bruker FT-IR Tensor-27 infrared spectrophotometer with KBr disks. 1D and 2D NMR spectra were recorded on Bruker DRX-400, DRX-500, and DRX-600 spectrometers using TMS as an internal standard. Chemical shifts (d) were expressed in ppm with reference to the solvent signals. ESI-MS and EI-MS (HR-EI-MS) analysis were carried out on Waters Xevo TQS and Waters AutoSpec Premier P776 mass spectrometers, respectively. Semipreparative HPLC was performed on a Waters 600 with a COSMOSIL C 18 (10 9 250 mm) column. Silica gel (100-200 and 200-300 mesh, Qingdao Marine Chemical Co., Ltd., People's Republic of China), and MCI gel (75-150 lm, Mitsubishi Chemical Corporation, Tokyo, Japan) were used for column chromatography. Fractions were monitored by thin-layer chromatography (TLC) (GF254, Qingdao Marine Chemical Co., Ltd.), and spots were visualized by 10% sulfuric acid ethanol solution and dragendorff reagent.
Plant Material
The stem of L. barbarum were collected from 
Extraction and Isolation
The air-dried and powdered sample (10.0 kg) was extracted with 85% aqueous EtOH (40 L 9 3) under reflux conditions for 3 h each time, and the solvent was evaporated in vacuum. 
Anticancer Activities
GSC-3# and GSC-12# were human glioma stem cell lines that were established by Kunming institute of zoology from two human glioblastoma multiform samples. The glioma stem cell was cultured in serum-free medium DMEM F12 supplied with 1xB27 and 50 ng/mL EGF, BFGF and 1% penicillin/streptomycin. The glioma stem cells were seeded in the laminin pre-coating dishes and cultured in 37°C, 5% CO 2 incubator. Cell viability assay was performed by the MTS method as previously described. GSCs were digested and counted, seeded in laminin pre-coating 96-well-plate with 20000 cells/well. The compounds were added with a serial gradient concentration (40, 20, 10, 5, 2.5, 1.25, 0.625, 0.3125 lg/mL) and cultured in cell incubator for 72 h. MTS reagent was diluted 1:5 with fresh medium and mixed well. The old medium was removed and subsequently the fresh medium was added with 100 lL/well. The cells were incubated for 1.5 h. Absorbance was measured by Hybrid Reader (BioTek synergy H1) at 490 nm. The cell viability was evaluated by percentage compared with DMSO control group. The half-maximal inhibitory concentration (IC 50 ) was measured and calculated by Graph Pad Prism 5 software.
Supporting Information
1D, 2D NMR spectra, ESIMS/MS, HRESIMS, UV and IR of compounds 1-4 and influence of deuterated solvent on the 1 H NMR spectra of compounds 3 and 6 are available).
